Joining forces against SARS-CoV-2: Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine
Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2 Commercial production will be conducted in Laupheim, Germany Rentschler Biopharma’s innovative and highly flexible business model enables fast, high-quality, large-scale manufacturing for commercial supply as well as small batch production for clinical trials for other BioNTech RNA product candidates LAUPHEIM, GERMANY and MILFORD, MA, USA – EQS Newswire – 8 October […]